| Disease | anaphylaxis |
| Comorbidity | C0155877|allergic asthma |
| Sentences | 2 |
| PubMedID- 26340860 | To better understand the risk of anaphylaxis in patients with allergic asthma receiving omalizumab, a post-marketing pharmacosurveillance study was initiated in 2009. |
| PubMedID- 24456365 | Cheonggukjang ethanol extracts inhibit a murine allergic asthma via suppression of mast cell-dependent anaphylactic reactions. |
Page: 1